iBio (IBIO) Net Equity Issued and Repurchased (2012 - 2026)
iBio (IBIO) posted quarterly Net Equity Issued and Repurchased of $3.3 million for Q1 2026, up 193.7% year-over-year from $1.1 million in Q1 2025, and up 1411.42% quarter-over-quarter from $219000.0 in Q3 2025.
iBio (IBIO) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends
iBio (IBIO) has reported Net Equity Issued and Repurchased for 11 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased rose 193.7% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $5.9 million (down 61.56% YoY), while the FY2025 annual figure was $3.5 million, down 86.13% from the prior year.
- Net Equity Issued and Repurchased climbed to $3.3 million in Q1 2026 per IBIO's latest filing, from $219000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $14.3 million in Q2 2024 and bottomed at $4000.0 in Q3 2024.
- Historically, Net Equity Issued and Repurchased has averaged $3.2 million across 4 years, with a median of $2.4 million in 2025.
- Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased tumbled 99.86% — and 2025, when it surged 5375.0%.
- iBio's Net Equity Issued and Repurchased stood at $100000.0 in 2023, then plunged by 96.0% to $4000.0 in 2024, then soared by 5375.0% to $219000.0 in 2025, then jumped by 1411.42% to $3.3 million in 2026.
- Business Quant data shows IBIO's Net Equity Issued and Repurchased at $3.3 million in Q1 2026, $219000.0 in Q3 2025, and $2.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.31 Mn |
| Mar 31, 2026 | 3.31 Mn |
| Sep 30, 2025 | 219,000.00 |
| Sep 30, 2025 | 219,000.00 |
| Jun 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 14.32 Mn |
| Jun 30, 2024 | 14.32 Mn |
| Mar 31, 2024 | 4.28 Mn |
| Mar 31, 2024 | 4.28 Mn |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 2.81 Mn |
| Sep 30, 2023 | 2.81 Mn |
| Sep 30, 2018 | 1.35 Mn |
| Sep 30, 2018 | 1.35 Mn |